CareSuper wins ‘MySuper of the Year’ for 2018

18 October 2017
CareSuper CEO Julie Lander with our ‘MySuper of the Year’ award.
CareSuper CEO Julie Lander with our ‘MySuper of the Year’ award.

Each year, the best funds in the superannuation industry come together for the SuperRatings ‘Fund of the Year’ awards. It’s an opportunity for funds that have delivered an exceptional product and service offering to be recognised for their achievements – and in turn, for members to see how their super fund stacks up against the competition.

We’re pleased to say that CareSuper was part of the small group of high-achievers who took home awards at the event last week, receiving both the ‘Best Growth Return 2012–2017’ award and the prestigious ‘MySuper of the Year’ award for 2018.

How is the award a win for members?

The ‘MySuper of the Year’ win highlights CareSuper’s commitment to producing a quality, streamlined super product backed by a proven investment strategy – CareSuper’s MySuper (or Balanced) option.

CareSuper’s MySuper (Balanced) option aims to effectively meet the needs of most members for the long-term. And the proof is in the pudding. Comparisons between the average net benefit of surveyed retails funds and CareSuper show that CareSuper’s Balanced option added $26,000 more to its members’ accounts over a 10-year period, based on modelling by SuperRatings.*

Backed by industry experts

SuperRatings, which is an independent researcher and ratings agency, assesses hundreds of super products offered by publicly available funds in Australia for the annual awards. To be shortlisted, CareSuper had to demonstrate performance against a range of criteria including investments, fees, administration, member servicing, insurance and governance. As the winner, CareSuper was judged as having the ‘best value for money default offering’.

A privilege to be recognised

CareSuper CEO, Julie Lander, said the team felt honoured by the win. ‘We work hard to deliver an exceptional product that provides a strong, long-term net benefit to members. Winning this award gives us confidence that we’re on the right track.

And of course, we do so much more than this to add value to our members. Whether it’s through insurance, education or communications to help them take control of their finances to deliver a better lifestyle, we always strive to deliver a super option that suits members’ needs and offers value for money,’ she said

‘It is a privilege to be able to make a positive difference to people’s lives – and it’s a responsibility we take seriously.’

Could you be better off with CareSuper?

Is your super with a fund that’s consistently rated one of the best? See how your super compares today – it’s quick and easy to check.

About SuperRatings

SuperRatings is an independent researcher that provides analysis and insight into the super industry. It reviews and rates over 600 super and pension products.

Our awards

Take a look at the other awards we've won.

*Comparisons modelled by SuperRatings, commissioned by ISA Pty Ltd ABN 72 158 563 270 Corporate Authorised Representative No. 426006 of Industry Fund Services Ltd ABN 54 007 016 195 AFSL 232514. Modelled outcome assumes a starting balance of $50,000 and initial salary of $50,000 and shows the 10-year average difference in net benefit of CareSuper’s Balanced option and the main balanced options of 77 retail funds tracked by SuperRatings, with a 10-year performance history, taking into account historical earnings and fees (excluding contribution, entry, exit and additional advisor fees) of main balanced options. Outcomes vary between individual funds. Modelling as at 30 June 2017.

This information is general advice only and has been prepared without taking into account your particular financial needs, circumstances or objectives. Past performance is not a reliable indicator of future performance and should never be the sole factor considered when selecting a fund. The number of retail super funds surveyed also varies for each period. You should consider your own investment objectives, financial situation and needs and read the appropriate product disclosure statement before making an investment decision. You may also wish to consult a licensed financial adviser.